CAR-T

[bkoffman]

Hi,

CAR-T therapy just keeps getting better in CLL. Please take a look at my interview with Dr. Siddiqi from ASH 2018: cllsociety.org/2019/07/ash-...

Stay strong. We are all in this together

.

Brian

[JigFettler Volunteer]

Thank you Brian.

Quite incredible progress indeed.

Indeed, sophisticated medical science.

Jig

[Redlion]

As someone who is 14 months into Ibrutinib mono therapy and TP53 mutated this is a wonderful insight into the future of the treatment of this disease. Thanks for sharing.

[mrsjsmith in reply to Redlion]

Hi Redlion,

I am almost the same as you TP53 and have been on Ibrutinib slightly longer. All positive news is good Nooz !

🙂

[Smakwater]

Very Encouraging!

JM

[MaxSmart]

Brian, thank you for your tireless work on behalf of CLL research and education. You are an inspiration!

[MaxSmart]

Brian, what’s your best guess of the when this might be available more widely available?

[bkoffman CLL CURE Hero]

Just a guess, but 2 years or more. Funding is a big challenge.